213 related articles for article (PubMed ID: 17182233)
1. In vitro and in vivo evaluation of the transdermal iontophoretic delivery of sumatriptan succinate.
Patel SR; Zhong H; Sharma A; Kalia YN
Eur J Pharm Biopharm; 2007 May; 66(2):296-301. PubMed ID: 17182233
[TBL] [Abstract][Full Text] [Related]
2. Zelrix: a novel transdermal formulation of sumatriptan.
Pierce M; Marbury T; O'Neill C; Siegel S; Du W; Sebree T
Headache; 2009 Jun; 49(6):817-25. PubMed ID: 19438727
[TBL] [Abstract][Full Text] [Related]
3. Controlled non-invasive transdermal iontophoretic delivery of zolmitriptan hydrochloride in vitro and in vivo.
Patel SR; Zhong H; Sharma A; Kalia YN
Eur J Pharm Biopharm; 2009 Jun; 72(2):304-9. PubMed ID: 18771728
[TBL] [Abstract][Full Text] [Related]
4. Development and evaluation of occlusive systems employing polyvinyl alcohol for transdermal delivery of sumatriptan succinate.
Balaguer-Fernández C; Padula C; Femenía-Font A; Merino V; Santi P; López-Castellano A
Drug Deliv; 2010 Feb; 17(2):83-91. PubMed ID: 20067437
[TBL] [Abstract][Full Text] [Related]
5. Nasal drug delivery of sumatriptan succinate.
Chavanpatil MD; Vavia PR
Pharmazie; 2005 May; 60(5):347-9. PubMed ID: 15918583
[TBL] [Abstract][Full Text] [Related]
6. Using transdermal iontophoresis to increase granisetron delivery across skin in vitro and in vivo: effect of experimental conditions and a comparison with other enhancement strategies.
Cázares-Delgadillo J; Ganem-Rondero A; Quintanar-Guerrero D; López-Castellano AC; Merino V; Kalia YN
Eur J Pharm Sci; 2010 Mar; 39(5):387-93. PubMed ID: 20096354
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins.
Dubey S; Kalia YN
J Control Release; 2010 Aug; 145(3):203-9. PubMed ID: 20423719
[TBL] [Abstract][Full Text] [Related]
8. In vitro transdermal iontophoretic delivery of penbutolol sulfate.
Ita KB; Banga AK
Drug Deliv; 2009 Jan; 16(1):11-4. PubMed ID: 19555303
[TBL] [Abstract][Full Text] [Related]
9. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
[TBL] [Abstract][Full Text] [Related]
10. Combination strategies for enhancing transdermal absorption of sumatriptan through skin.
Femenía-Font A; Balaguer-Fernández C; Merino V; López-Castellano A
Int J Pharm; 2006 Oct; 323(1-2):125-30. PubMed ID: 16809010
[TBL] [Abstract][Full Text] [Related]
11. Delivery of ethinylestradiol from film forming polymeric solutions across human epidermis in vitro and in vivo in pigs.
Zurdo Schroeder I; Franke P; Schaefer UF; Lehr CM
J Control Release; 2007 Apr; 118(2):196-203. PubMed ID: 17289207
[TBL] [Abstract][Full Text] [Related]
12. Transdermal iontophoretic delivery of terbinafine hydrochloride: quantitation of drug levels in stratum corneum and underlying skin.
Sachdeva V; Siddoju S; Yu YY; Kim HD; Friden PM; Banga AK
Int J Pharm; 2010 Mar; 388(1-2):24-31. PubMed ID: 20025950
[TBL] [Abstract][Full Text] [Related]
13. Rapid absorption of sumatriptan powder and effects on glyceryl trinitrate model of headache following intranasal delivery using a novel bi-directional device.
Luthringer R; Djupesland PG; Sheldrake CD; Flint A; Boeijinga P; Danjou P; Demazières A; Hewson G
J Pharm Pharmacol; 2009 Sep; 61(9):1219-28. PubMed ID: 19703372
[TBL] [Abstract][Full Text] [Related]
14. Transdermal iontophoretic delivery of selegiline hydrochloride, in vitro.
Kolli CS; Chadha G; Xiao J; Parsons DL; Babu RJ
J Drug Target; 2010 Nov; 18(9):657-64. PubMed ID: 20038213
[TBL] [Abstract][Full Text] [Related]
15. Sumatriptan succinate transdermal delivery systems for the treatment of migraine.
Balaguer-Fernández C; Femenía-Font A; Del Rio-Sancho S; Merino V; López-Castellano A
J Pharm Sci; 2008 Jun; 97(6):2102-9. PubMed ID: 17854062
[TBL] [Abstract][Full Text] [Related]
16. Iontophoretic transdermal delivery of sumatriptan: effect of current density and ionic strength.
Femenía-Font A; Balaguer-Fernández C; Merino V; López-Castellano A
J Pharm Sci; 2005 Oct; 94(10):2183-6. PubMed ID: 16136550
[TBL] [Abstract][Full Text] [Related]
17. Transdermal iontophoresis of the dopamine agonist 5-OH-DPAT in human skin in vitro.
Nugroho AK; Li L; Dijkstra D; Wikström H; Danhof M; Bouwstra JA
J Control Release; 2005 Mar; 103(2):393-403. PubMed ID: 15763622
[TBL] [Abstract][Full Text] [Related]
18. Effect of iontophoresis on in vitro transdermal absorption of almotriptan.
Calatayud-Pascual MA; Balaguer-Fernández C; Serna-Jiménez CE; Del Rio-Sancho S; Femenía-Font A; Merino V; López-Castellano A
Int J Pharm; 2011 Sep; 416(1):189-94. PubMed ID: 21736929
[TBL] [Abstract][Full Text] [Related]
19. Design and in vivo evaluation of an indapamide transdermal patch.
Ren C; Fang L; Ling L; Wang Q; Liu S; Zhao L; He Z
Int J Pharm; 2009 Mar; 370(1-2):129-35. PubMed ID: 19114099
[TBL] [Abstract][Full Text] [Related]
20. Effect of chemical enhancers on the in vitro percutaneous absorption of sumatriptan succinate.
Femenía-Font A; Balaguer-Fernández C; Merino V; Rodilla V; López-Castellano A
Eur J Pharm Biopharm; 2005 Sep; 61(1-2):50-5. PubMed ID: 15925502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
